Bienaime Jean Jacques

DirectorImmunome Inc. (IMNM) · full profile →Form 4 · filed Mar 12, 2026
Net Buying
Open-Market Buys
$44K
Open-Market Sells
$0
Net Open-Market Flow
$44K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2026Buy(P)1K$21.55$22K38K
Mar 10, 2026Buy(P)1K$22.12$22K37K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001221590-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly: